CLN3 disease process: missense point mutations and protein depletion in vitro

Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural propert...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of paediatric neurology Vol. 5; pp. 81 - 88
Main Authors Golabek, Adam A., Kida, Elizabeth, Walus, Mariusz, Kaczmarski, Wojciech, Wujek, Piotr, Wisniewski, Krystyna E.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 2001
Subjects
Online AccessGet full text
ISSN1090-3798
1532-2130
DOI10.1053/ejpn.2000.0440

Cover

Abstract Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid- β protein precursor and cathepsin D in vitro. The Leu101 Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin.
AbstractList Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid-beta protein precursor and cathepsin D in vitro. The Leu101Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin.
Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid- β protein precursor and cathepsin D in vitro. The Leu101 Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin.
Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid-beta protein precursor and cathepsin D in vitro. The Leu101Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin.Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our knowledge of the physiological function of its gene product, CLN3 protein, is still incomplete. To gain more insight into the structural properties and function of CLN3 protein we studied at present: i) how the naturally occurring point mutations Arg334Cys and Leu101Pro affect the biological properties of CLN3 protein, and ii) whether depletion of CLN3 protein synthesis by using an antisense approach induces a distinct phenotype in cells of neuronal origin in vitro. Here we report that although both CLN3 mutant proteins are targeted to lysosomes, thus similar to wild-type CLN3 protein, they are devoid of the biological activity of wild-type CLN3 protein such as its effect on lysosomal pH or intracellular processing of amyloid-beta protein precursor and cathepsin D in vitro. The Leu101Pro mutation affected significantly the maturation and stability of CLN3 protein. The Arg334Cys mutation influenced mildly the maturation and turnover of CLN3 protein, but at the same time abolished the function of CLN3 protein in vitro, which suggests that the Arg334 may constitute a part of the active site of CLN3 protein. In addition, we show that depletion of CLN3 protein synthesis in human neuroblastoma cells in vitro induces outgrowth of long cellular processes and formation of cellular aggregates and affects the viability of these cells. This finding suggests that CLN3 protein is implicated in biological processes associated with the differentiation of cells of neuronal origin.
Author Golabek, Adam A.
Wisniewski, Krystyna E.
Walus, Mariusz
Kaczmarski, Wojciech
Kida, Elizabeth
Wujek, Piotr
Author_xml – sequence: 1
  givenname: Adam A.
  surname: Golabek
  fullname: Golabek, Adam A.
  email: golabekc@popmail.med.nyu.edu
– sequence: 2
  givenname: Elizabeth
  surname: Kida
  fullname: Kida, Elizabeth
– sequence: 3
  givenname: Mariusz
  surname: Walus
  fullname: Walus, Mariusz
– sequence: 4
  givenname: Wojciech
  surname: Kaczmarski
  fullname: Kaczmarski, Wojciech
– sequence: 5
  givenname: Piotr
  surname: Wujek
  fullname: Wujek, Piotr
– sequence: 6
  givenname: Krystyna E.
  surname: Wisniewski
  fullname: Wisniewski, Krystyna E.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11589014$$D View this record in MEDLINE/PubMed
BookMark eNp9kNtLwzAUh4Mo7qKvPkqffGvNrWvrmwxvMPVFn0OWnEJmm9YkG-y_N2UTYTAhkJPD9x1OfhN0ajsLCF0RnBGcs1tY9TajGOMMc45P0JjkjKaUMHwaa1zhlBVVOUIT71eRqjidnaMRIXlZYcLH6HW-eGOJNh6kh6R3nQLv75LWeA926HTGhqRdBxlMZ30irR6oAMYmGvoGhnYSHxsTXHeBzmrZeLjc31P0-fjwMX9OF-9PL_P7RaoYpiFlVSF1RXldc1lrBbrOlyVhJCeU1TVTjNKqYKAIl7GSVGnNKMezijAqJcZsim52c-Mq32vwQcSFFTSNtNCtvSgoKeMZwOs9uF62oEXvTCvdVvwGEIFsByjXee-g_kOwGBIWQ8JiSFgMCUeBHwjK7MIJTprmuFbuNIixbAw44ZUBG_9uHKggdGeOq7MDVTXGGiWbL9j-J_4ABfmkkQ
CitedBy_id crossref_primary_10_1016_j_neulet_2021_136117
crossref_primary_10_1097_00019052_200112000_00019
crossref_primary_10_2217_clp_11_70
Cites_doi 10.1016/0092-8674(95)90274-0
10.1038/8861
10.1093/hmg/8.6.1091
10.1006/mgme.1999.2834
10.1002/ana.410430118
10.1093/hmg/9.5.735
10.1055/s-2007-973663
10.1006/bbrc.1998.9272
10.1093/hmg/8.3.523
10.1212/WNL.52.2.360
10.1006/mgme.1999.2833
10.1016/S0014-5793(98)01425-2
10.1006/mgme.1999.2836
10.1006/mgme.1999.2837
10.1006/mgme.2000.3006
10.1093/hmg/7.1.85
10.1086/514846
10.1006/bbrc.1998.9210
10.1007/s004390050654
ContentType Journal Article
Copyright 2001 European Paediatric Neurology Society
Copyright_xml – notice: 2001 European Paediatric Neurology Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1053/ejpn.2000.0440
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-2130
EndPage 88
ExternalDocumentID 11589014
10_1053_ejpn_2000_0440
S1090379805800169
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: NS38988
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABJNI
ABMAC
ABMZM
ABTEW
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SPCBC
SSH
SSN
SSZ
T5K
Z5R
~G-
AACTN
AADPK
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c302t-397ad924ff4afdcedf5b81315123ff3c322973ec14a229a2cdd324069132aa003
IEDL.DBID .~1
ISSN 1090-3798
IngestDate Thu Sep 04 16:55:19 EDT 2025
Mon Jul 21 05:58:07 EDT 2025
Thu Apr 24 22:59:26 EDT 2025
Tue Jul 01 00:19:54 EDT 2025
Fri Feb 23 02:35:25 EST 2024
Tue Aug 26 16:32:13 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords CLN3
Mutations
Cell culture
Overexpression
Antisense experiments
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c302t-397ad924ff4afdcedf5b81315123ff3c322973ec14a229a2cdd324069132aa003
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 11589014
PQID 72182180
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_72182180
pubmed_primary_11589014
crossref_primary_10_1053_ejpn_2000_0440
crossref_citationtrail_10_1053_ejpn_2000_0440
elsevier_sciencedirect_doi_10_1053_ejpn_2000_0440
elsevier_clinicalkey_doi_10_1053_ejpn_2000_0440
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2001
2001-1-00
2001-00-00
20010101
PublicationDateYYYYMMDD 2001-01-01
PublicationDate_xml – year: 2001
  text: 2001
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle European journal of paediatric neurology
PublicationTitleAlternate Eur J Paediatr Neurol
PublicationYear 2001
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Järvelä, Sainio, Rantamaki (bib9) 1998; 7
Kaczmarski, Wisniewski, Golabek (bib6) 1999; 66
Croopnick, Choi, Muller (bib11) 1998; 250
Pearce, Ferea, Nosel (bib12) 1999; 22
Michalewski, Kaczmarski, Golabek (bib5) 1998; 253
Zhong, Wisniewski, Kaczmarski (bib21) 1998; 102
Sidell, Sarafian, Kelly (bib27) 1986; 54
Ohkuma, Moriyama, Takano (bib25) 1982; 79
Kremmidiotis, Lensink, Bilton (bib13) 1999; 8
Järvelä, Lehtovirta, Tikkanen (bib15) 1999; 8
Pearce, Carr, Das, Sherman (bib17) 1999; 96
Lauronen, Munroe, Järvelä (bib22) 1999; 2
Batten (bib1) 1903; 23
Towbin, Staehelin, Gordon (bib23) 1979; 76
Wisniewski, Zhong, Kaczmarski (bib20) 1998; 43
The International Batten Disease Consortium (bib2) 1995; 82
Munroe, Mitchison, O'Rawe (bib19) 1997; 61
Ohkuma, Poole (bib24) 1978; 75
Forgac (bib26) 1998; 440
Kaczmarski, Kida, Lach (bib3) 1997; 28
Kida, Kaczmarski, Golabek (bib7) 1999; 66
Katz, Gao, Prabhakaram (bib14) 1997; 38
Haskell, Carr, Pearce (bib10) 2000; 9
Pearce, Sherman (bib16) 1998; 95
Golabek, Kaczmarski, Kida (bib4) 1999; 66
Puranam, Guo, Qian (bib18) 1999; 66
Golabek, Kida, Walus (bib8) 2000; 70
Croopnick (10.1053/ejpn.2000.0440_bib11) 1998; 250
Katz (10.1053/ejpn.2000.0440_bib14) 1997; 38
The International Batten Disease Consortium (10.1053/ejpn.2000.0440_bib2) 1995; 82
Pearce (10.1053/ejpn.2000.0440_bib17) 1999; 96
Michalewski (10.1053/ejpn.2000.0440_bib5) 1998; 253
Munroe (10.1053/ejpn.2000.0440_bib19) 1997; 61
Kida (10.1053/ejpn.2000.0440_bib7) 1999; 66
Puranam (10.1053/ejpn.2000.0440_bib18) 1999; 66
Sidell (10.1053/ejpn.2000.0440_bib27) 1986; 54
Forgac (10.1053/ejpn.2000.0440_bib26) 1998; 440
Golabek (10.1053/ejpn.2000.0440_bib8) 2000; 70
Ohkuma (10.1053/ejpn.2000.0440_bib25) 1982; 79
Kaczmarski (10.1053/ejpn.2000.0440_bib6) 1999; 66
Pearce (10.1053/ejpn.2000.0440_bib12) 1999; 22
Järvelä (10.1053/ejpn.2000.0440_bib9) 1998; 7
Lauronen (10.1053/ejpn.2000.0440_bib22) 1999; 2
Kaczmarski (10.1053/ejpn.2000.0440_bib3) 1997; 28
Batten (10.1053/ejpn.2000.0440_bib1) 1903; 23
Haskell (10.1053/ejpn.2000.0440_bib10) 2000; 9
Järvelä (10.1053/ejpn.2000.0440_bib15) 1999; 8
Golabek (10.1053/ejpn.2000.0440_bib4) 1999; 66
Wisniewski (10.1053/ejpn.2000.0440_bib20) 1998; 43
Towbin (10.1053/ejpn.2000.0440_bib23) 1979; 76
Ohkuma (10.1053/ejpn.2000.0440_bib24) 1978; 75
Pearce (10.1053/ejpn.2000.0440_bib16) 1998; 95
Zhong (10.1053/ejpn.2000.0440_bib21) 1998; 102
Kremmidiotis (10.1053/ejpn.2000.0440_bib13) 1999; 8
References_xml – volume: 28
  start-page: 33
  year: 1997
  end-page: 36
  ident: bib3
  article-title: Expression studies of CLN3 protein
  publication-title: Neuropediatrics
– volume: 96
  start-page: 11341
  year: 1999
  end-page: 11345
  ident: bib17
  article-title: Phenotypic reversal of the btnl defects in yeast by chloroquine: A yeast model for Batten disease
  publication-title: Proc Natl Acad Sci USA
– volume: 102
  start-page: 57
  year: 1998
  end-page: 62
  ident: bib21
  article-title: Molecular screening of Batten disease: identification of a missense mutation (E295K) in the CLN3 gene
  publication-title: Hum Genet
– volume: 38
  start-page: 2375
  year: 1997
  end-page: 2386
  ident: bib14
  article-title: Immunochemical localization of the Batten disease (CLN3) protein in retina
  publication-title: Invest Ophthalmol Vis Sci
– volume: 82
  start-page: 949
  year: 1995
  end-page: 957
  ident: bib2
  article-title: Isolation of a novel gene underlying Batten disease, CLN3
  publication-title: Cell
– volume: 8
  start-page: 523
  year: 1999
  end-page: 531
  ident: bib13
  article-title: The Batten disease gene product (CLN3p) is a Golgi integral membrane protein
  publication-title: Hum Mol Genet
– volume: 76
  start-page: 4350
  year: 1979
  end-page: 4359
  ident: bib23
  article-title: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets:procedure and some applications
  publication-title: Proc Natl Acad Sci USA
– volume: 70
  start-page: 203
  year: 2000
  end-page: 213
  ident: bib8
  article-title: CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-
  publication-title: Mol Genet Metab
– volume: 8
  start-page: 1091
  year: 1999
  end-page: 1098
  ident: bib15
  article-title: Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
  publication-title: Hum Mol Genet
– volume: 75
  start-page: 3327
  year: 1978
  end-page: 3331
  ident: bib24
  article-title: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
  publication-title: Proc Natl Acad Sci USA
– volume: 43
  start-page: 106
  year: 1998
  end-page: 110
  ident: bib20
  article-title: Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis
  publication-title: Ann Neurol
– volume: 66
  start-page: 294
  year: 1999
  end-page: 308
  ident: bib18
  article-title: Cln3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide
  publication-title: Mol Genet Metab
– volume: 61
  start-page: 310
  year: 1997
  end-page: 316
  ident: bib19
  article-title: Spectrum of mutations in the Batten disease gene, CLN3
  publication-title: Am J Hum Genet
– volume: 79
  start-page: 2758
  year: 1982
  end-page: 2762
  ident: bib25
  article-title: Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence
  publication-title: Proc Natl Acad Sci USA
– volume: 66
  start-page: 277
  year: 1999
  end-page: 282
  ident: bib4
  article-title: Expression studies of CLN3 protein associated with a juvenile form of neuronal ceroid lipofuscinosis in mammalian cells
  publication-title: Mol Genet Metab
– volume: 7
  start-page: 85
  year: 1998
  end-page: 90
  ident: bib9
  article-title: Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
  publication-title: Hum Mol Genet
– volume: 250
  start-page: 335
  year: 1998
  end-page: 341
  ident: bib11
  article-title: The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in juvenile form of Batten disease
  publication-title: Biochem Biophys Res Comm
– volume: 440
  start-page: 258
  year: 1998
  end-page: 263
  ident: bib26
  article-title: Structure, function and regulation of the vacuolar (H+)-ATPases
  publication-title: FEBS Lett
– volume: 66
  start-page: 261
  year: 1999
  end-page: 264
  ident: bib6
  article-title: Studies of membrane association of CLN3 protein
  publication-title: Mol Genet Metab
– volume: 22
  start-page: 55
  year: 1999
  end-page: 58
  ident: bib12
  article-title: Action of BTN1, the yeast orthologue of the gene mutated in Batten disease
  publication-title: Nature Gen
– volume: 54
  start-page: 287
  year: 1986
  end-page: 300
  ident: bib27
  article-title: Retinoic acidinduced differentiation of human neuroblastoma: a cell variant system showing two distinct responses
  publication-title: Exp Cell Biol
– volume: 253
  start-page: 458
  year: 1998
  end-page: 462
  ident: bib5
  article-title: Evidence for phosphorylation of CLN3 protein associated with Batten disease
  publication-title: Biochem Biophys Res Commun
– volume: 66
  start-page: 265
  year: 1999
  end-page: 271
  ident: bib7
  article-title: Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro
  publication-title: Mol Genet Metab
– volume: 9
  start-page: 735
  year: 2000
  end-page: 744
  ident: bib10
  article-title: Batten disease: evaluation of CLN3 mutations on protein localization and function
  publication-title: Hum Mol Genet
– volume: 2
  start-page: 360
  year: 1999
  end-page: 365
  ident: bib22
  article-title: Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis
  publication-title: Neurology
– volume: 95
  start-page: 6915
  year: 1998
  end-page: 6918
  ident: bib16
  article-title: A yeast model for the study of Batten disease
  publication-title: Proc Natl Acad Sci USA
– volume: 23
  start-page: 386
  year: 1903
  end-page: 390
  ident: bib1
  article-title: Cerebral degeneration with etrical changes in the maculae in two members of a family
  publication-title: Trans Ophthalmol Soc UK
– volume: 75
  start-page: 3327
  year: 1978
  ident: 10.1053/ejpn.2000.0440_bib24
  article-title: Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
– volume: 82
  start-page: 949
  year: 1995
  ident: 10.1053/ejpn.2000.0440_bib2
  article-title: Isolation of a novel gene underlying Batten disease, CLN3
  publication-title: Cell
  doi: 10.1016/0092-8674(95)90274-0
– volume: 22
  start-page: 55
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib12
  article-title: Action of BTN1, the yeast orthologue of the gene mutated in Batten disease
  publication-title: Nature Gen
  doi: 10.1038/8861
– volume: 38
  start-page: 2375
  year: 1997
  ident: 10.1053/ejpn.2000.0440_bib14
  article-title: Immunochemical localization of the Batten disease (CLN3) protein in retina
  publication-title: Invest Ophthalmol Vis Sci
– volume: 8
  start-page: 1091
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib15
  article-title: Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/8.6.1091
– volume: 66
  start-page: 294
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib18
  article-title: Cln3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide
  publication-title: Mol Genet Metab
  doi: 10.1006/mgme.1999.2834
– volume: 43
  start-page: 106
  year: 1998
  ident: 10.1053/ejpn.2000.0440_bib20
  article-title: Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis
  publication-title: Ann Neurol
  doi: 10.1002/ana.410430118
– volume: 9
  start-page: 735
  year: 2000
  ident: 10.1053/ejpn.2000.0440_bib10
  article-title: Batten disease: evaluation of CLN3 mutations on protein localization and function
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/9.5.735
– volume: 28
  start-page: 33
  year: 1997
  ident: 10.1053/ejpn.2000.0440_bib3
  article-title: Expression studies of CLN3 protein
  publication-title: Neuropediatrics
  doi: 10.1055/s-2007-973663
– volume: 96
  start-page: 11341
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib17
  article-title: Phenotypic reversal of the btnl defects in yeast by chloroquine: A yeast model for Batten disease
– volume: 250
  start-page: 335
  year: 1998
  ident: 10.1053/ejpn.2000.0440_bib11
  article-title: The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in juvenile form of Batten disease
  publication-title: Biochem Biophys Res Comm
  doi: 10.1006/bbrc.1998.9272
– volume: 8
  start-page: 523
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib13
  article-title: The Batten disease gene product (CLN3p) is a Golgi integral membrane protein
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/8.3.523
– volume: 95
  start-page: 6915
  year: 1998
  ident: 10.1053/ejpn.2000.0440_bib16
  article-title: A yeast model for the study of Batten disease
– volume: 79
  start-page: 2758
  year: 1982
  ident: 10.1053/ejpn.2000.0440_bib25
  article-title: Identification and characterization of a proton pump on lysosomes by fluorescein-isothiocyanate-dextran fluorescence
– volume: 2
  start-page: 360
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib22
  article-title: Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis
  publication-title: Neurology
  doi: 10.1212/WNL.52.2.360
– volume: 54
  start-page: 287
  year: 1986
  ident: 10.1053/ejpn.2000.0440_bib27
  article-title: Retinoic acidinduced differentiation of human neuroblastoma: a cell variant system showing two distinct responses
  publication-title: Exp Cell Biol
– volume: 66
  start-page: 261
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib6
  article-title: Studies of membrane association of CLN3 protein
  publication-title: Mol Genet Metab
  doi: 10.1006/mgme.1999.2833
– volume: 440
  start-page: 258
  year: 1998
  ident: 10.1053/ejpn.2000.0440_bib26
  article-title: Structure, function and regulation of the vacuolar (H+)-ATPases
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(98)01425-2
– volume: 66
  start-page: 277
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib4
  article-title: Expression studies of CLN3 protein associated with a juvenile form of neuronal ceroid lipofuscinosis in mammalian cells
  publication-title: Mol Genet Metab
  doi: 10.1006/mgme.1999.2836
– volume: 23
  start-page: 386
  year: 1903
  ident: 10.1053/ejpn.2000.0440_bib1
  article-title: Cerebral degeneration with etrical changes in the maculae in two members of a family
  publication-title: Trans Ophthalmol Soc UK
– volume: 66
  start-page: 265
  year: 1999
  ident: 10.1053/ejpn.2000.0440_bib7
  article-title: Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro
  publication-title: Mol Genet Metab
  doi: 10.1006/mgme.1999.2837
– volume: 70
  start-page: 203
  year: 2000
  ident: 10.1053/ejpn.2000.0440_bib8
  article-title: CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-β protein precursor and cathepsin D in humancells
  publication-title: Mol Genet Metab
  doi: 10.1006/mgme.2000.3006
– volume: 7
  start-page: 85
  year: 1998
  ident: 10.1053/ejpn.2000.0440_bib9
  article-title: Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/7.1.85
– volume: 61
  start-page: 310
  year: 1997
  ident: 10.1053/ejpn.2000.0440_bib19
  article-title: Spectrum of mutations in the Batten disease gene, CLN3
  publication-title: Am J Hum Genet
  doi: 10.1086/514846
– volume: 253
  start-page: 458
  year: 1998
  ident: 10.1053/ejpn.2000.0440_bib5
  article-title: Evidence for phosphorylation of CLN3 protein associated with Batten disease
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1998.9210
– volume: 102
  start-page: 57
  year: 1998
  ident: 10.1053/ejpn.2000.0440_bib21
  article-title: Molecular screening of Batten disease: identification of a missense mutation (E295K) in the CLN3 gene
  publication-title: Hum Genet
  doi: 10.1007/s004390050654
– volume: 76
  start-page: 4350
  year: 1979
  ident: 10.1053/ejpn.2000.0440_bib23
  article-title: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets:procedure and some applications
SSID ssj0009426
Score 1.5542349
Snippet Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our...
Although the CLN3 gene associated with the disease process in subjects with the juvenile form of neuronal ceroid lipofuscinosis was discovered in 1995, our...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 81
SubjectTerms Antisense Elements (Genetics)
Antisense experiments
Cell culture
Child
CLN3
Humans
In Vitro Techniques
Kidney - cytology
Membrane Glycoproteins
Microscopy, Confocal
Molecular Chaperones
Mutation, Missense
Mutations
Neuroblastoma
Neuronal Ceroid-Lipofuscinoses - genetics
Neuronal Ceroid-Lipofuscinoses - metabolism
Neurons - cytology
Neurons - enzymology
Overexpression
Proteins - analysis
Proteins - genetics
Proteins - metabolism
Transfection
Tumor Cells, Cultured
Title CLN3 disease process: missense point mutations and protein depletion in vitro
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1090379805800169
https://dx.doi.org/10.1053/ejpn.2000.0440
https://www.ncbi.nlm.nih.gov/pubmed/11589014
https://www.proquest.com/docview/72182180
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LSsQwMCwK4kV8vzUHwVNsa5I29bYsyvrYveiCt5K2KVQ0Lbtdj367M324eFgPQg9tmLRhZjIz6bwIufBjzZM4UUwZGTCRhS4LfWlYKgXXIuBBqvF_x2jsDyfi4VW-9sigy4XBsMpW9jcyvZbW7YjTYtMp89x5xpBCHoTKlQoNF0ziE_B24Omrr0WYRyjqlmsIzBC6K9wouWPeyroCqnuFfZeXKaZlhmetgO42yUZrOdJ-s7gt0jN2m6yNWt_4DhkNnsactg4XWjYJADf0Ax3uFkeK3Fb0Y9743mdU25TWVRpyS1NTYhHuwlJ4-MyrabFLJne3L4Mha5slsIS71xUDu0KncJjKMqGzFLCXyVh5HBU6zzKewMYNA24ST2i409dJmvI67RWOo1rD3t4jK7aw5oDQQGpfaQ9o5cYi1r4OfVBisYemFPYYOiSsw1SUtJXEsaHFe1R7tCWPELPY4NKNELOH5PIHvmxqaCyFdDrER11mKMiyCMT70hnez4xffPPnnPOOphEQAT0k2ppiPosCrGfvKYDYb0i9WK8nFXqcj_7xvWOy3kSu4XVCVqrp3JyCKVPFZzWvnpHV_v3jcPwNN1rwkQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELagSMCCeL-pByQmk6S282BDFVWBpgutxGY5iSMFgRNByshvx5dHEUMYkDIk1lmx7py7c757IHTpRpLGUewTX3GPsDSwSeByRRLOqGQe9RIJ_zvCqTues4dn_ryChm0uDIRVNrq_1umVtm5GrIabVpFl1hOEFFIv8G3ug-MSrKI1xqkHcX3XXz9xHgGreq4BNQHytnIjp5Z6KaoSqPY1NF7uskxdnmdlgUbbaKtxHfFtvbodtKL0LloPG3B8D4XDyZTiBnHBRZ0BcIPfAHHXMJJnusRvixp8_8BSJ7gq05BpnKgCqnDnGpuHz6x8z_fRfHQ3G45J0y2BxNQelMQ4FjIxp6k0ZTJNDPtSHvkOBYtO05TG5ssNPKpih0lzJwdxktAq79WcR6U0H_cB6ulcqyOEPS5dXzpGWHbEIunKwDVWLHLAl4ImQ8eItJwScVNKHDpavIoK0uZUAGehw6UtgLPH6GpJX9RFNDoprZbxok0NNcpMGP3eOcNZzvi1cf6c029lKowQACKRWuWLD-FBQXvHNxSHtah_1utwHyDnk3-8r482xrNwIib308dTtFmHscF1hnrl-0KdG7-mjC6qffsNytryJA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CLN3+disease+process%3A+missense+point+mutations+and+protein+depletion+in+vitro&rft.jtitle=European+journal+of+paediatric+neurology&rft.au=Golabek%2C+Adam+A.&rft.au=Kida%2C+Elizabeth&rft.au=Walus%2C+Mariusz&rft.au=Kaczmarski%2C+Wojciech&rft.date=2001&rft.pub=Elsevier+Ltd&rft.issn=1090-3798&rft.eissn=1532-2130&rft.volume=5&rft.spage=81&rft.epage=88&rft_id=info:doi/10.1053%2Fejpn.2000.0440&rft.externalDocID=S1090379805800169
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1090-3798&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1090-3798&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1090-3798&client=summon